Shanthi Rexaline

Shanthi is a contributor to InvestorPlace.com and works as a Staff Writer with Benzinga. Equipped with a Bachelor’s degree in Agriculture and an MBA with specialization in finance and marketing, she has about two decades of experience in financial reporting and analysis, and specializes in the biopharma and EV sectors.

Recent Articles

8 Tech Stock Winners & Losers From Q4

By Shanthi Rexaline

Entering the third year of the pandemic, tech stocks are at crossroads. The pandemic presented them with both adversities and opportunities.

7 EV Stocks With Key Product Launches In 2022

By Shanthi Rexaline

EV stocks have gotten off to a weak start in 2022, but compelling new products could serve as key catalysts to reverse sentiment.

Avoid Novavax for Now, Until the Picture Clears Up

By Shanthi Rexaline

NVAX stock may have seen a near-term bounce following the completion of filing of EUA filing with the FDA, but it may not be a buy yet.

Nio’s Underperformance Makes It One of the Best Chinese EV Stocks for 2022

By Shanthi Rexaline

NIO stock hasn't kept up with other EV Stocks, but that should change if it executes on its strategy and resolve production issues.

How Dogecoin Is Shaping Up to Start the Week

By Shanthi Rexaline

Dogecoin, once an darling among crypto investors, has retreated sharply since the middle of 2021, and the broader cryptocurrency market sell-off has served to exacerbate the weakness. Does the meme currency has in itself to turn things around?

Load More